Rachel R.
- Country
- France
- Department
- Département Pédiatrie Multidisciplinaire
Research Overview
- Efficacy of Semaglutide in Children Aged 12–17 Years with Hypothalamic Obesity Secondary to Craniopharyngioma: A Randomized Controlled Trial
- A Multicenter Randomized Non‑Inferiority Trial of Weekly Somatrogon versus Daily Somatropin in Pediatric Patients with Small‑for‑Gestational‑Age or Idiopathic Short Stature
- A Comparative Study of Somapacitan and Somatropin in Pediatric Patients with Short Stature Due to SGA, Turner Syndrome, Noonan Syndrome, or Idiopathic Short Stature
Data & Insights
Has run more than one trial at 48 of 120 partner sites.
Specializations
Metabolic Disorders
The investigator specializes in treating Type 1 Diabetes Mellitus and obesity in adolescents, with particular focus on innovative therapeutic approaches.
- Type 1 Diabetes Management
- Adolescent Weight Management
- Metabolic Comorbidities
Their work encompasses comprehensive treatment strategies for weight-related health conditions in young patients.
Growth Disorders
Focuses on treating various growth-related conditions including Hypochondroplasia, Turner Syndrome, and Noonan Syndrome.
- Growth Velocity Assessment
- Short Stature Treatment
- Growth Hormone Response
Expertise extends to managing complex genetic conditions affecting childhood growth and development.
Genetic Conditions
Specializes in managing genetic disorders including Prader-Willi Syndrome and Heterozygous Familial Hypercholesterolemia in pediatric populations.
- Long-term Disease Management
- Pediatric Lipid Disorders
- Genetic Growth Disorders
Dedicated to developing therapeutic strategies for rare genetic conditions affecting children.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.